BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31902593)

  • 1. Race and socioeconomic differences associated with endovascular peripheral vascular interventions for newly diagnosed claudication.
    Hicks CW; Wang P; Bruhn WE; Abularrage CJ; Lum YW; Perler BA; Black JH; Makary MA
    J Vasc Surg; 2020 Aug; 72(2):611-621.e5. PubMed ID: 31902593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overuse of early peripheral vascular interventions for claudication.
    Hicks CW; Holscher CM; Wang P; Black JH; Abularrage CJ; Makary MA
    J Vasc Surg; 2020 Jan; 71(1):121-130.e1. PubMed ID: 31208940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice patterns surrounding the use of tibial interventions for claudication in the Medicare population.
    Bose S; Dun C; Sorber R; Stonko DP; Solomon AJ; Black JH; Lum YW; Conte MS; Makary MA; Hicks CW
    J Vasc Surg; 2023 Feb; 77(2):454-462.e1. PubMed ID: 36058433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia.
    Sorber R; Dun C; Kawaji Q; Abularrage CJ; Black JH; Makary MA; Hicks CW
    J Vasc Surg; 2023 Mar; 77(3):836-847.e3. PubMed ID: 37276171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Index atherectomy peripheral vascular interventions performed for claudication are associated with more reinterventions than nonatherectomy interventions.
    Kawaji Q; Dun C; Walsh C; Sorber RA; Stonko DP; Abularrage CJ; Black JH; Perler BA; Makary MA; Hicks CW
    J Vasc Surg; 2022 Aug; 76(2):489-498.e4. PubMed ID: 35276258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in Comorbidities Explain Black-White Disparities in Outcomes After Femoropopliteal Endovascular Intervention.
    Krawisz AK; Natesan S; Wadhera RK; Chen S; Song Y; Yeh RW; Jaff MR; Giri J; Julien H; Secemsky EA
    Circulation; 2022 Jul; 146(3):191-200. PubMed ID: 35695005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between sex and long-term outcomes of endovascular treatment for peripheral artery disease.
    Ramkumar N; Suckow BD; Behrendt CA; Mackenzie TA; Sedrakyan A; Brown JR; Goodney PP
    Catheter Cardiovasc Interv; 2023 Apr; 101(5):877-887. PubMed ID: 36924009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprint of: Early peripheral vascular interventions for claudication are associated with higher rates of late interventions and progression to chronic limb threatening ischemia.
    Sorber R; Dun C; Kawaji Q; Abularrage CJ; Black JH; Makary MA; Hicks CW
    J Vasc Surg; 2023 Jun; 77(6):1720-1731.e3. PubMed ID: 37225352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial Differences in Presentation and Outcomes After Peripheral Arterial Interventions: Insights From the NCDR-PVI Registry.
    Julien HM; Wang Y; Curtis JP; Johnston-Cox H; Eberly LA; Wang GJ; Nathan AS; Fanaroff AC; Khatana SAM; Groeneveld PW; Secemsky EA; Eneanya ND; Vora AN; Kobayashi T; Barbery C; Chery G; Kohi M; Kirksey L; Armstrong EJ; Jaff MR; Giri J
    Circ Cardiovasc Interv; 2023 Jun; 16(6):e011485. PubMed ID: 37339237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in hospital treatments for peripheral arterial disease in the United States and association between payer status and quality of care/outcomes, 2007-2011.
    Kim LK; Swaminathan RV; Minutello RM; Gade CL; Yang DC; Charitakis K; Shah A; Kaple R; Bergman G; Singh H; Wong SC; Feldman DN
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):864-72. PubMed ID: 26446891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Outcomes of Endovascular Infrapopliteal Interventions for Intermittent Claudication.
    Mullins CH; Novak Z; Axley JC; Sutzko DC; Spangler EL; Pearce BJ; Patterson MA; Passman MA; Haverstrock BD; Siracuse JJ; Beck AW; McFarland GE
    Ann Vasc Surg; 2021 Jan; 70():79-86. PubMed ID: 32866579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Unique All-Payer Rate-Setting System Controls the Cost but Not the Racial Disparity in Lower Extremity Revascularization Procedures.
    Nejim B; Beaulieu RJ; Alshaikh H; Hamouda M; Canner J; Malas MB
    Ann Vasc Surg; 2018 Oct; 52():116-125. PubMed ID: 29783031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional variation in patient selection and treatment for lower extremity vascular disease in the Vascular Quality Initiative.
    Soden PA; Zettervall SL; Curran T; Vouyouka AG; Goodney PP; Mills JL; Hallett JW; Schermerhorn ML;
    J Vasc Surg; 2017 Jan; 65(1):108-118. PubMed ID: 27692467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated with Amputation after Peripheral Vascular Intervention for Intermittent Claudication.
    Axley JC; McFarland GE; Novak Z; Scali ST; Patterson MA; Pearce BJ; Spangler EL; Passman MA; Beck AW
    Ann Vasc Surg; 2020 Jan; 62():133-141. PubMed ID: 31494265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent claudication treatment patterns in the commercially insured non-Medicare population.
    Siracuse JJ; Woodson J; Ellis RP; Farber A; Roddy SP; Kalesan B; Levin SR; Osborne NH; Srinivasan J
    J Vasc Surg; 2021 Aug; 74(2):499-504. PubMed ID: 33548437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preexisting Conditions Determine the Occurrence of Unplanned Readmissions after Procedures for Treatment of Peripheral Arterial Disease.
    Aziz F; Lehman EB
    Ann Vasc Surg; 2018 Jul; 50():60-72. PubMed ID: 29481929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of state tobacco control policies with active smoking at the time of intervention for intermittent claudication.
    Levin SR; Hawkins SS; Farber A; Goodney PP; Osborne NH; Tan TW; Malas MB; Patel VI; Siracuse JJ
    J Vasc Surg; 2021 May; 73(5):1759-1768.e1. PubMed ID: 33098941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for 30-day unplanned readmission following infrainguinal endovascular interventions.
    Bodewes TC; Soden PA; Ultee KH; Zettervall SL; Pothof AB; Deery SE; Moll FL; Schermerhorn ML
    J Vasc Surg; 2017 Feb; 65(2):484-494.e3. PubMed ID: 28126175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racial Heterogeneity in Treatment Effects in Peripheral Artery Disease: Insights From the CLEVER Trial (Claudication: Exercise Versus Endoluminal Revascularization).
    Pokharel Y; Jones PG; Graham G; Collins T; Regensteiner JG; Murphy TP; Cohen D; Spertus JA; Smolderen K
    Circ Cardiovasc Qual Outcomes; 2018 Apr; 11(4):e004157. PubMed ID: 29643064
    [No Abstract]   [Full Text] [Related]  

  • 20. Sex-Based Assessment of Patient Presentation, Lesion Characteristics, and Treatment Modalities in Patients Undergoing Peripheral Vascular Intervention.
    Ramkumar N; Suckow BD; Brown JR; Sedrakyan A; Cronenwett JL; Goodney PP
    Circ Cardiovasc Interv; 2018 Jan; 11(1):e005749. PubMed ID: 29326151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.